苯达莫司汀联合利妥昔单抗与R-CHOP方案一线治疗惰性非霍奇金淋巴瘤或套细胞淋巴瘤疗效及安全性比较
Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin´s Lymphoma or Mantle Cell Lymphoma
苯达莫司汀联合利妥昔单抗与R-CHOP方案一线治疗惰性非霍奇金淋巴瘤或套细胞淋巴瘤疗效及安全性比较 |
|
评价者：张馨予 |
Efficacy and Safety of Bendamustine plus Rituximab Compared with CHOP plus Rituximab as First-Line Treatment for Patients with Indolent Non-Hodgkin´s Lymphoma or Mantle Cell Lymphoma |
| |